← All stocks

Amneal Pharmaceuticals, Inc.

AMRX Net selling

CIK 0001723128 #1201 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$9.82M

$0.00 on a plan · $1.57M straight out of an exercise

Sold at will

$8.25M

6 of 7 sales

Net

−$9.82M

−$8.25M against sales at will

By person

16 insiders · 8 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Shah Nikita

Executive Vice President

—

$4.14M (2)

−$4.14M

253,390

0.0793%

$4.47M

−13.1%

Daly Jason B.

EVP, Chief Legal Officer

—

$3.77M (2)

−$3.77M

35,171

0.0110%

$620.42K

−38.6%

Kiely John

Director

—

$882.00K (1)

−$882.00K

200,252

0.0627%

$3.53M

−21.7%

Nark Ted C

Director

—

$586.00K (1)

−$586.00K

325,848

0.1020%

$5.75M

+8.3%

Autor Deborah M.

Director

—

$450.56K (1)

−$450.56K

93,660

0.0293%

$1.65M

+0.3%

Patel Tushar Bhikhubhai

10% owner

—

61,341,678

19.21%

$1.08B

+14.5%

Patel Chirag K.

President & Co-CEO

—

7,775,204

2.43%

$137.15M

+1,417%

Patel Chintu

Co-CEO

—

7,770,255

2.43%

$137.07M

+1,416%

Patel Gautam

Director

—

1,927,595

0.6036%

$34.00M

−5.9%

MEISTER PAUL M

Director

—

832,800

0.2608%

$14.69M

+14.4%

Konidaris Tasos

Executive Vice President & CFO

—

449,434

0.1407%

$7.93M

−14.8%

George Jeffrey P.

Director

—

344,614

0.1079%

$6.08M

+27.9%

Yanai Shlomo

Director

—

320,804

0.1005%

$5.66M

+30.6%

BUCHI J KEVIN

Director

—

282,520

0.0885%

$4.98M

−54.3%

Alva Emily Peterson

Director

—

211,029

0.0661%

$3.72M

−15.8%

BOYER ANDREW S

Executive Vice President

—

193,646

0.0606%

$3.42M

−24.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

BUCHI J KEVIN

11 Sep 2026

Director

Exercised, kept

20,445

$14.45

$295.43K

Kiely John

13 Aug 2026

Director

Sell

50,000

$17.64

$882.00K

Daly Jason B.

12 Aug 2026

EVP, Chief Legal Officer

Sell

210,000

$17.40

$3.65M

Shah Nikita

12 Aug 2026

Executive Vice President

Sell

146,403

$17.51

$2.56M

Daly Jason B.

11 Aug 2026

EVP, Chief Legal Officer

Sell

6,613

$17.70

$117.05K

Autor Deborah M.

11 May 2026

Director

Sell

34,819

$12.94

$450.56K

Nark Ted C

17 Nov 2025

Director

Sell

50,000

$11.72

$586.00K

Shah Nikita

12 Nov 2025

Executive Vice President

Sold after exercise

131,856

$11.92

$1.57M

What was left out

Form 4 filings counted 34

Amendments (4/A) skipped 2

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 6

Transactions with no price 0

Shares from compensation/vesting 32,293,019

History held since 8 May 2018